chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Congestion every morning and evening; This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (Congestion every morning and evening) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In July 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced NASAL CONGESTION (Congestion every morning and evening). At the time of the report, NASAL CONGESTION (Congestion every morning and evening) had not resolved.            No concomitant medications were reported. No treatment medications were reported. Patient did not go to doctors.
Hi. I am registered nurse. I got my vaccine 08/10/21 at pharmacy at 09:15 am. I felt fatigue and and pain/soreness on my left arm. It feel heavy too. I had my bowel movement today four times already. First three times of my BM, the stool?s consistency was semi-formed. My latest bowel movement which was around 11:45 pm - 08/10/21. It was a bright red bloody stool. I am worried and still watching out for my symptoms. I don?t have a primacy care physician right now because I don?t have insurance. Can you help me with this?
swelling in her joints including her knees; has been in tears from the pain; has touch flares on her skin; the skin was super red; had swelling in her hands and feet; couldn't walk at one point and needed to be pushed in a wheelchair; pain in her hands and feet; welt marks all over her stomach; had an itchy response; This spontaneous case was reported by a nurse and describes the occurrence of PRURITUS (had an itchy response), JOINT SWELLING (swelling in her joints including her knees), PAIN (has been in tears from the pain), SKIN SENSITISATION (has touch flares on her skin) and ERYTHEMA (the skin was super red) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 056A22A, 049E21A and 051C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 15-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Jun-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Jun-2022, the patient experienced PRURITUS (had an itchy response) and URTICARIA (welt marks all over her stomach). On an unknown date, the patient experienced JOINT SWELLING (swelling in her joints including her knees), PAIN (has been in tears from the pain), SKIN SENSITISATION (has touch flares on her skin), ERYTHEMA (the skin was super red), PERIPHERAL SWELLING (had swelling in her hands and feet), GAIT DISTURBANCE (couldn't walk at one point and needed to be pushed in a wheelchair) and PAIN IN EXTREMITY (pain in her hands and feet). The patient was treated with TRIAMCINOLONE ACETONIDE (KENALOG [TRIAMCINOLONE ACETONIDE]) at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, PRURITUS (had an itchy response), JOINT SWELLING (swelling in her joints including her knees), PAIN (has been in tears from the pain), SKIN SENSITISATION (has touch flares on her skin), ERYTHEMA (the skin was super red), PERIPHERAL SWELLING (had swelling in her hands and feet), PAIN IN EXTREMITY (pain in her hands and feet) and URTICARIA (welt marks all over her stomach) outcome was unknown and GAIT DISTURBANCE (couldn't walk at one point and needed to be pushed in a wheelchair) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2022, Blood test: white count was up.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication details were not reported by the reporter. Patient had some blood work done which showed that white count was up. Patient was also taking oral steroids as treatment drug.
PT is having severe shooting pain along her right arm. This started after getting the shot and is still having the pain 6 days. Patient says she felt the pharmacist hit the bone and is believes this is the reason for the pain. Patient does not have the means to go see a doctor to be evaluated. Unsure what is the cause of the pain in the arm.
Information has been received from a registered pharmacist and a licensed practical nurse (nurse manager) concerning an 81 year old white retired female in a long term care facility with allergies to penicillin and sulfa drugs, Parkinson's disease and osteoporosis and a history of an influenza vaccination (lot no. E04861KA), administered on 10/09/01, IM in the right deltoid and within 2-3 hours developed a red, warm area just below the site of injection. Concomitant therapy included Paxil, Prilosec, Altace, estrogens, Prempro, ferrous sulfate, Miacalcin, ibuprofen, Klor-Con, Viactiv, Tylenol, cyanocobalamin, acetaminophen (+) propoxyphene hydrochloride and "centravites." The pt developed significant swelling and discomfort. Subsequently, the pt was treated by her physician with antibiotics and dressings applied for comfort. On 10/13/01, the pt recovered. On 3/5/02, at 14:00 the pt was vaccinated with pneumococcal vaccine 23 polyvalent (lot 641027/1051L), IM in teh right deltoid. Concomitant therapy included Paxil, Prilosec, Altace, estrogens, Prempro, ferrous sulfate, Miacalcin, ibuprofen, Klor-Con, Viactiv, Tylenol, cyaocobalamin, acetaminophen (+) propoxyphene hydrochloride and "centravites." On 3/6/02 at 6:00, the pt awoke with complaints of redness, edema and a warm area at the injection site. The pt had developed a sore, very red arm at the site of the injection. The pharmacy and the physician were notified. The physician visited the pt and ordered Keflex, 500mg, three times a day for seven days. The pt was medicated for pain as necessary. The pt was treated with "dressings to prevent skin tears due to the pt's small smze, large bruising and edema." The licensed practical nurse reported that no long-term effects were noted and the pt healed within 7-10 days. The pt recovered on 3/15/02. The licensed practical nurse reported that the injection site redness, edema, warmth, soreness/pain and bruising were considered to be other medical events. The registered pharmacist and the licensed practical nurse reported that another pt was vaccinated with penumococcal vaccine 23 polyvalent (lot 641027/1051L) from the same multidose vial and developed a sore, very red arm at the site of the injection (WAES0206USA02743). No additional info is expected.
Swelling of the tongue reported as tongue thickness at the back of the throat lasting 2-3 days. Patient denied difficulty breathing and denied difficulty swallowing.
Pt experienced scattered large urticarial lesions approximately 45 minutes after injection. Lasted for one hour. Pt was chewing bubble gum when rash occurred.
vaccinated while pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (vaccinated while pregnant) in a 40-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE for an unknown indication.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The patient's last menstrual period was on 15-Jul-2020 and the estimated date of delivery was 20-Apr-2021. On 27-Feb-2021, the patient experienced EXPOSURE DURING PREGNANCY (vaccinated while pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirty-second week of the pregnancy.  On 27-Feb-2021, EXPOSURE DURING PREGNANCY (vaccinated while pregnant) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medication was provided by the reporter.  Patient gave consent for safety to Follow-up.
Pt was present at office for physical exam on 9/23/16 and was given MENACTRA and Flu vaccine on Right Deltoid arm. Patient came back two days later on 9/27/16 complaining of pain from fingers to right arm. Right hand weakness and loss of strength some at vaccination. No prior reaction to vaccines, no fever, no swelling, at site of injections.
Patient returned to pharmacy one day post vaccination both arms red, swollen, itchy painful. Recommended 10cc BENADRYL and follow up with MD. Patient consulted MD, given antibiotic.
After my booster in November 2021, I started spotting shortly after my booster was administered. I am 15 years post menopausal and have had no periods or spotting until after my booster.  My Gynocologist did a biopsy in December. Reslutls were negative for cancer.  Bleeding and spooting continued and She also performed a D&C and Hysterscopy 3/17.  Results for cancer were negative and one polyp was removed.  Post surgery, bleeding has continue for no known reason.  I want to report this as a vaccination side effect and be advised as to what studies are onging.  My research has proved this is not an isolated incident and many women have reported the same - most women would not know where or how to report.
approx 12 hrs p/inject had been cranky, fussy & feverish since inject then had t106 or above; called ER advised give alcohol baths & take temp till it decreases;
12-4-02 Received HBV #2, HAV #1, IPV. 12-5-02 rash develops upper part of body. 12-9-02 no other sx developed. Rash still visible but improving.
Burning up and severe chills: States these were like she never had before. Used four blankets and bed pillows trying to warm up; she felt so hot/ she figured it was about 104/ burning up/ Temperature around 100 and 101; she is exhausted; Pains in toes and finger joints; This is a spontaneous report from a contactable consumer (patient). A 64-year-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection, Batch/Lot number: EP7534), via an unspecified route of administration, administered in arm left on 30Mar2021 12:30 PM (at the age of 64-year-old) as single dose for COVID-19 immunization. The patient medical history included inflammatory eye problem (patient had this 10 year. Does not think this is anything related), ileostomy for 50 years. The patient took no concomitant medications. No family medical history. The patient did not receive any other vaccines prior vaccinations within 4 weeks. No additional vaccines administered on same date. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection, Batch/Lot number: ED6203), via an unspecified route of administration on 09Mar2021 (at the age of 64-year-old) for COVID-19 immunization and experienced pain in extremity, injection site mass, injection site swelling, injection site erythema, rash. Patient stated she was reporting side effects again. Stated that she reported after the first dose, where she had problems with her arm, reported having a big lump and rash. Patient stated that she got the shot on Tuesday, was fine all afternoon and evening. On an unspecified date in 2021 during the night she felt so hot, wouldn't even take her temp because she figured it was about 104. Burning up and severe chills: Stated these were like she never had before. Used four blankets and bed pillows trying to warm up. Temperature around 100 and 101: Stated that this started the next day, which was yesterday that it has been staying between 100 and 101. Stated she was exhausted. Pains in toes and finger joints: Stated that this was going on now and has no muscle soreness or aching. The patient received Motrin as a treatment. Outcome of the events was unknown.
Patient had reaction to vaccines given (09/11/2019) in the same left arm (boostrix and flu) at pharmacy. Patient came back to pharmacy on the 09/20/2019 with a left red, swollen, hot, mottled, and itchy arm. Patient instructed to see primary care doctor or an urgent clinic. Primary care doctor informed of incident.
Booster dose; Body aches (joints, ankles and feet, mostly on left side); headache; fatigue; swollen lymph nodes (armpit & collarbone); This is a spontaneous report from a contactable consumer (Pfizer colleague). A 39-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE,), dose 3 intramuscular, administered in Arm Left on 04Nov2021 (at the age of 39-years-old) (Batch/Lot Number: F93527) as single dose for covid-19 immunisation in Pharmacy or Drug Store. The patient was not pregnant. The patient was not pregnant at time of vaccination. Medical history included seafood allergy from an unknown date. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number EP6955) via Intramuscular in the left arm on 26Mar2021, and the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number EW0162) via Intramuscular in the left arm on 31Jul2021 at single dose for covid-19 immunisation and experienced Dose 1: 26Mar2021, dose 2: 31Jul2021. The patient experienced booster dose on 04Nov2021, body aches (joints, ankles and feet, mostly on left side), headache, fatigue, swollen lymph nodes (armpit & collarbone) on 04Nov2021. Event did not result in Emergency Room Visit nor Physician Office Visit. No Treatment was Received for the events other than booster dose. The outcome of the events other than booster dose was recovering.    Follow-up attempts are completed. No further information is expected.
I wasn't feeling well on Saturday. I woke up Sunday morning with a high fever of 102. I had a headache and then two days later I had a sore throat. I had some laryngitis. I'm not sure how long the fever lasted and I had the laryngitis for 2 weeks. Tuesday was when I went to go see the doctor because I must have still had the fever. The temperature was going down because of TYLENOL, but 5 hours later it would go back up.
Information has been received from a currently 57 years old female subject (who is the physician also) regarding herself who was enrolled in a clinical trial for VARIVAX (Merck). The subject's concurrent conditions, relevant medical history and concomitant medications were not reported. On an unknown date in 1990 (reported as 25 years ago), the subject was vaccinated with VARIVAX (Merck) (dose and route unspecified) as part of a clinical trial. The subject could not remember if she received total of two or three doses of VARIVAX (Merck) in the clinical trial. On an unknown date, the subject's titer was drawn and she could remember being told that she did not develop good immunity to varicella after completing VARIVAX (Merck) doses (antibody test negative). Since vaccination was so long ago, the subject could not remember what the exact titer level was but she stated she did not seroconvert after receiving VARIVAX (Merck) doses from clinical trial. No treatment was rendered for the event and no product quality complaint was filed. The outcome of the event was unknown. The causal relationship of the event with study therapy and study procedure was not reported. Additional information has been requested.
RECEIVED FLU VACCINE ON 3/23/18. ON 3/24/18 REPORTED TO FATHER THAT LT ARM WAS SORE AND PAINFUL WHEN MOVING IT. I OBSERVED THAT ARM APPEARED SWOLLEN AND WARM TO THE TOUCH. PT STATED NO PAIN ANYWHERE ELSE. PT HAD NOT TAKEN ANY PAIN RELIEVER PRIOR TO REPORTING EVENT TO US.
This case was reported by a consumer via interactive digital media and described the occurrence of feels awful in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced feels awful. On an unknown date, the outcome of the feels awful was unknown.   It was unknown if the reporter considered the feels awful to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient felt awful after first dose of Shingles vaccine. The patient gets his/her second vaccine after 2nd January 2021. The patient stated that he/she would not like to get shingles again as that was a living hell. The follow-up could not be possible as no contact details were available.
This spontaneous report was received from a nurse, referring to a 39 year old patient, the gender was not reported. Concurrent conditions included that the patient was HIV positive. Historical drugs included that the patient received the first dose of PREVNAR 13 in July 2017. Information regarding medical history or concomitant medication was not provided. On 28-NOV-2018, the patient received the second dose of PREVNAR 13 (route, anatomical site of administration, lot number and expiration date were not reported). Subsequently, on 19-DEC-2018, the patient was vaccinated with PNEUMOVAX 23 (route, anatomical site of administration, lot number and expiration date were not reported) for prophylaxis. No adverse effects reported.
pt recv vax 13MAR98 & 14MAR97 pt exp a 3x3cm sl raised erythema @ site & ran a 103.4 fever initially, then 101 for 72hr;
sore arm; It took the caller a long time to get to sleep; she would only sleep for 3-4 hours then she would wake up groggy and really tired; she would only sleep for 3-4 hours then she would wake up groggy and really tired; Excitability; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 54-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), administered in arm right, administration date 27Mar2021 (Lot number: EN6208) at the age of 54 years as dose 1, single for COVID-19 immunisation. Relevant medical history included: "Neck injury" (unspecified if ongoing), notes: from a car accident; "shoulder inury" (unspecified if ongoing), notes: from a car accident. Concomitant medication(s) included: ASPIRIN (E.C.), start date: 2019; SIMVASTATIN; NOVOLOG MIX (70/30); NYSTATIN.  The following information was reported: AGITATION (non-serious) with onset 27Mar2021, outcome "recovering", described as "Excitability"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "sore arm"; INSOMNIA (non-serious), outcome "unknown", described as "It took the caller a long time to get to sleep"; SOMNOLENCE (non-serious), FATIGUE (non-serious), outcome "unknown" and all described as "she would only sleep for 3-4 hours then she would wake up groggy and really tired".  No follow-up attempts are possible. No further information is expected.
Patients have been administered from vaccines that experienced a T excursion; Patients have been administered from vaccines that experienced a T excursion; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a T excursion) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a T excursion) in a 36-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2022, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 10-Mar-2022, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a T excursion). On 23-Mar-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a T excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered from vaccines that experienced a T excursion) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered from vaccines that experienced a T excursion) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. It was reported that excursion duration was approximately 7 hours. The product was refrigerated at the time of excursion. Max Temperature reached was 64°F. There was no change in vaccine state on visual inspection. No treatment information was provided.
DIFFICULTY BREATHING; HEADACHES (NOT THAT BAD); This spontaneous report received from a patient concerned a 54 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: chronic back pain, non-alcohol user, cigarette smoker, liver problem, chronic obstructive pulmonary disease (copd), and sulfa allergy, and other pre-existing medical conditions included: Patient has no drug abuse or illicit drug usage. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: 207A21A, and expiry: UNKNOWN) dose was not reported, administered on 02-SEP-2021 for prophylactic vaccination. No concomitant medications were reported.  On SEP-2021, the patient experienced headaches (not that bad). On 04-SEP-2021, the patient experienced difficulty breathing. The action taken with covid-19 vaccine was not applicable. The outcome of the difficulty breathing and headaches (not that bad) was not reported. This report was non-serious.
HEADACHE; LOWER BACK PAIN; PAIN IN GROIN AREA; LEG PAIN; This spontaneous report received from a patient concerned a 25 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018, expiry: UNKNOWN) dose was not reported, administered on 06-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On MAY-2021, the subject experienced lower back pain. On MAY-2021, the subject experienced pain in groin area. On MAY-2021, the subject experienced leg pain. Laboratory data included: Pain scale (NR: not provided) 7/8 out of 10. On 07-MAY-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from headache on 07-MAY-2021, and the outcome of leg pain, lower back pain and pain in groin area was not reported. This report was non-serious.
Two days after the vaccines were given, patient's  left arm became red and swollen from shoulder to elbow.  She did not have fever and was not complaining of discomfort.  Mother took her to the doctor who put her on Keflex. The swelling is subsiding.
Chills, aches, nausea, extreme dizziness lightheaded, fatigue, itchiness in throat, stomach upset,